MyAverix Finance
NS · Pharmaceuticals
Glenmark Pharmaceuticals Ltd (GLENMARK)
Pharmaceuticals & Biotechnology
Glenmark Pharmaceuticals Ltd (GLENMARK) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $613.79B, P/E ratio is -305.48, net margin is 23.9%, dividend yield is 0.11%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for GLENMARK
Glenmark Pharmaceuticals Ltd (GLENMARK) — FAQ
What is Glenmark Pharmaceuticals Ltd's market cap?
Glenmark Pharmaceuticals Ltd (GLENMARK) has a reported market cap of $613.79B (data as of 2026-07-10).
What is GLENMARK's P/E ratio?
The price-to-earnings (P/E) ratio for Glenmark Pharmaceuticals Ltd (GLENMARK) is -305.48 (data as of 2026-07-10).
Does Glenmark Pharmaceuticals Ltd pay a dividend?
Glenmark Pharmaceuticals Ltd (GLENMARK) shows a reported dividend yield of 0.11%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).
What sector is Glenmark Pharmaceuticals Ltd in?
Glenmark Pharmaceuticals Ltd (GLENMARK) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
What exchange is GLENMARK listed on?
GLENMARK is listed on NS.
What is Glenmark Pharmaceuticals Ltd's net margin?
Glenmark Pharmaceuticals Ltd (GLENMARK) reports a net margin of 23.9% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.